Inventor · disambiguated record
Jing Teng
Also filed as: TENG JING
7 granted patents·12 pending applications·11 citations·filing 2011–2025
76Inventor score
Top patents by PatentIndex Score
19 records- 0185US12152037B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·7 claims
- 0283US9737610B2Formulations of rifaximin and uses thereofSELBO JON·Filed 2014·Granted Aug 22, 2017·9 cites·15 claims
- 0379US11339168B2Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitorsKRONOS BIO INC·Filed 2020·Granted May 24, 2022·1 cites·4 claims
- 0474US2025313566A1CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORSKRONOS BIO INC·Filed 2024·Application pending·0 cites
- 0566US2025223270A1Sulfonamide Compounds and Use ThereofTAIHO PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0665US2020397904A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0760US12344588B2Sulfonamide compounds and use thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 1, 2025·0 cites·27 claims
- 0859US2025115622A1Crystalline Forms Of An MCL-1 InhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 0959US2022007682A1Method for preparing an ipp- and vpp-rich hydrolysate from wheat gluten protein by enzymatic hydrolysisUNIV QINGDAO AGRICULTURAL·Filed 2021·Application pending·0 cites
- 1058US2025122224A1Crystalline Salt and Solvate Forms Of Murizatoclax (AMG 397)AMGEN INC·Filed 2023·Application pending·0 cites
- 1155US2017333562A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 1249US2012077835A1Formulations of rifaximin and uses thereofSELBO JON·Filed 2011·Application pending·0 cites
- 1348US12479808B2Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereofVTV THERAPEUTICS LLC·Filed 2021·Granted Nov 25, 2025·0 cites·28 claims
- 1448US2023357308A1Crystalline sodium cholesteryl sulfonateDURECT CORP·Filed 2021·Application pending·0 cites
- 1545US2023219910A1Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereofVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 1644US10813938B2Polymorphs of cocrystals of epigallocatechin gallate and caffeineAMRI SSCI LLC·Filed 2016·Granted Oct 27, 2020·0 cites·8 claims
- 1741US10072029B2Crystalline form of a proteasome inhibitorMILLENNIUM PHARM INC·Filed 2016·Granted Sep 11, 2018·0 cites·23 claims
- 1840US2020323815A1Amorphous dispersions of epigallocatechin gallateAMRI SSCI LLC·Filed 2018·Application pending·0 cites
- 1930US2013158264A1Polymorphs of OSI-906CASTELHANO ARLINDO L·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing Teng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →